Cancer vaccines: providing the edge in oncology
pharmaphorum
FEBRUARY 9, 2022
Closely related to this is the fact that global spending on oncology drugs reached $164 billion in 2020, with drug sales growing at a compound annual growth rate of 14.3% The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment. A broad front.
Let's personalize your content